ArticleJournal of molecular histology2026
The ameliorate effect of 18-beta glycyrrhetinic acid against cadmium-induced reproductive damage.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quercetin and hesperidin attenuate cyclophosphamide-induced renal injury in rats.Journal of molecular histology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate whether 18β-glycyrrhetinic acid (GA) could protect against cadmium-induced testicular damage in male rats. Twenty-four adult male Sprague Dawley rats were randomly divided into four groups (n = 6): Control, Cadmium (CAD), GA, and Cadmium + GA. Cadmium and GA were administered at doses of 1 mg/kg and 100 mg/kg, respectively, for 50 days. At the end of the experimental period, testicular and epididymal tissues were collected for biochemical, molecular, histopathological, and immunohistochemical analyses. Biochemical evaluations included oxidative stress parameters (TAS, TOS) and inflammatory cytokines (TNF-α, IL-6). Apoptotic gene expression (Bcl-2, Bax, Caspase-3) was assessed by RT-PCR. Histopathological and immunohistochemical analyses were performed to evaluate Bcl-2, Bax, iNOS, and NF-κB expression. Cadmium exposure significantly increased oxidative stress and inflammatory cytokine levels and induced marked histological damage, including Leydig cell necrosis and severe tubular degeneration. Immunohistochemical analysis revealed increased Bax, iNOS, and NF-κB expression in testicular and epididymal tissues. Cadmium also upregulated Bax and Caspase-3 while downregulating Bcl-2 gene expression. Conversely, GA treatment significantly attenuated cadmium-induced oxidative stress, inflammation, apoptosis, and histological damage. These findings suggest that GA exerts protective effects against cadmium-induced testicular toxicity and may represent a promising therapeutic agent for preventing cadmium-related male infertility.
Indexed as
Identifiers
42249195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.